---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-051967"
form_type: "8-K"
ticker: "NXTS"
cik: "0001789192"
company_name: "Nexentis Technologies Inc."
filed_at: "2024-12-26T23:59:59+00:00"
generated_at: "2026-05-28T23:20:56.793194+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# N2OFF loans $250K to MitoCareX; issues 650K shares to directors

## Summary
- Loaned $250,000 to MitoCareX Bio Ltd. at Israel Tax Authority rate + 3%, due in six months.
- Loan guaranteed by L.I.A. Pure Capital Ltd. If MitoCareX becomes a subsidiary, outstanding amount deducted from future allocations.
- Issued 650,000 common shares to directors under 2022 Share Incentive Plan on December 23, 2024.
- Board and compensation committee recommended issuance; non-binding stockholder approval received November 13, 2024.

## SEC filing metadata
- accession: 0001493152-24-051967
- form_type: 8-K
- ticker: NXTS
- cik: 0001789192
- company_name: Nexentis Technologies Inc.
- filed_at: 2024-12-26T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1789192/000149315224051967/0001493152-24-051967-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1789192/000149315224051967/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-051967
- JSON: https://secwatch.observer/filing/0001493152-24-051967.json
- Plain text: https://secwatch.observer/filing/0001493152-24-051967.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.